Post stroke epilepsy
Conditions
Interventions
Research group:Levetiracetam tablets,The initial dose is 0.5g/time, twice a day, orally administered, and then the dose is adjusted according to the recovery of the condition, increasing to 1.0g/time,
control group:oxcarbazepine tablets,The initial dose is 8-10mg/Kg, taken orally twice a day, and then adjusted according to the recovery of the condition. The maximum daily dose should not exceed 600m
Sponsors
Daizhuang Hospital in Shandong Province
Eligibility
Sex/Gender
All
Age
36 Years to 76 Years
Inclusion criteria
Inclusion criteria: 1. Meets the diagnostic criteria outlined in the Minutes of the 6th National Conference on Cerebrovascular Disease; 2. Diagnosis of cerebrovascular disease by cranial CT or MR; 3. Complete case data; 4. Both the patient and their relatives were informed and voluntarily joined this trial.
Exclusion criteria
Exclusion criteria: 1. Individuals with combined cognitive impairment, communication disorders, history of primary epilepsy, severe infections, and malignant tumors; 2. History of drug dependence or allergy; 3. Poor compliance and inability to cooperate with treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| electroencephalogram; | — |
Secondary
| Measure | Time frame |
|---|---|
| Interleukin-2;Interleukin-6;Enolase;Tumor necrosis factor - a;Adverse reactions; | — |
Countries
China
Contacts
Public ContactWang Zhonggang
Daizhuang Hospital in Shandong Province
Outcome results
None listed